TailorMed
PrivateLast Round
Series C
Nov 21, 2024
Total Funding Raised
$90M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
TailorMed is a healthcare technology company that provides an end-to-end financial navigation platform designed to help patients, providers, pharmacies, and life sciences companies reduce financial barriers to care.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Patient Engagement, Revenue Cycle, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TailorMed Comparables
Compare TailorMed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Annexus Health | 92% | |
| Atlas Health | 88% | |
| Cencora | 73% |
TailorMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 21, 2024 | ||||
| Series B | Nov 21, 2024 | ||||
| Series B | Sep 15, 2021 | ||||
| Series A | Jun 20, 2019 |
Key People
Founding team and executive leadership
TailorMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University Hospitals Ventures | Series B |
| BrightEdge | Series B, Series C |
| UnityPoint Health Ventures | Series B, Series C |
| OSF Ventures | Series B |
| Sanara Ventures | Series B, Series A, Series C, Seed |
| Allumia Ventures | Series C, Series B |
| BrightEdge | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2026
Supported over 75 million patients since 2020.
- Apr 7, 2026
Reached over 945 hospitals, 4,700 clinics, and 3,100 pharmacies.
Recent news
Latest coverage and updates
- attends_eventSep 22, 2026
TailorMed participates in the National Association of Specialty Pharmacy (NASP) InSPire 2026 conference as co-founder and CEO Srulik Dvorsky is scheduled to moderate an AI-focused patient services panel in Maryland on Sep 23rd '26.
TailorMed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TailorMed's valuation, stock price, and market status.
Is TailorMed a public or private company?
TailorMed is a private company.
What is the current stock price of TailorMed?
TailorMed is a private company, so its shares have no public market price. Caplight tracks TailorMed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TailorMed worth (valuation)?
Valuation information for TailorMed is not publicly available.
Can I buy TailorMed stock?
TailorMed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TailorMed's last funding round?
TailorMed's most recent funding round was Series C on November 21, 2024.
Who are the main investors in TailorMed?
Key investors in TailorMed include Sanara Ventures, Allumia Ventures, Windham Capital Partners, Poalim Equity, Triventures.
Will TailorMed IPO soon?
No public IPO plans have been announced for TailorMed.
How can I track TailorMed secondary market activity?
Caplight tracks bids, offers, and trades in TailorMed's shares on secondary markets.